Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

The Lancet
Jan 29, 2022 Volume 399 Number 10323 p411-494, e2
https://www.thelancet.com/journals/lancet/issue/current

 

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Lulu Bravo, et al.